- FOLD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $44.1 million.
- FOLD has traded 249,815 shares today.
- FOLD is down 3.1% today.
- FOLD was up 10.3% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in FOLD with the Ticky from Trade-Ideas. See the FREE profile for FOLD NOW at Trade-Ideas More details on FOLD: Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Currently there are 3 analysts that rate Amicus Therapeutics a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Amicus Therapeutics has been 2.5 million shares per day over the past 30 days. Amicus has a market cap of $473.0 million and is part of the health care sector and drugs industry. The stock has a beta of 1.76 and a short float of 8.1% with 0.16 days to cover. Shares are up 163.8% year-to-date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.